BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37424462)

  • 1. Decreased Cerebrovascular Reactivity in Mild Cognitive Impairment Phenotypes.
    Glass Umfleet L; Pommy J; Cohen AD; Allen M; Obarski S; Mason L; Berres H; Franczak M; Wang Y
    J Alzheimers Dis; 2023; 94(4):1503-1513. PubMed ID: 37424462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
    Putcha D; Tremont G
    J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Verbal Fluency Strategies among Individuals with Normal Cognition, Amnestic and Non-Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Bairami S; Folia V; Liampas I; Ntanasi E; Patrikelis P; Siokas V; Yannakoulia M; Sakka P; Hadjigeorgiou G; Scarmeas N; Dardiotis E; Kosmidis MH
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893577
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis.
    Yeung MK; Chau AK; Chiu JY; Shek JT; Leung JP; Wong TC
    Ageing Res Rev; 2022 Sep; 80():101675. PubMed ID: 35724862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI.
    Csukly G; Sirály E; Fodor Z; Horváth A; Salacz P; Hidasi Z; Csibri É; Rudas G; Szabó Á
    Front Aging Neurosci; 2016; 8():52. PubMed ID: 27065855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
    Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
    J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
    Kantarci K; Petersen RC; Przybelski SA; Weigand SD; Shiung MM; Whitwell JL; Negash S; Ivnik RJ; Boeve BF; Knopman DS; Smith GE; Jack CR
    Arch Neurol; 2008 Dec; 65(12):1621-8. PubMed ID: 19064749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography.
    Kim JG; Kim H; Hwang J; Kang SH; Lee CN; Woo J; Kim C; Han K; Kim JB; Park KW
    Sci Rep; 2022 Apr; 12(1):6219. PubMed ID: 35418202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages-Prevalence and effects on cognition.
    Haussmann R; Homeyer P; Sauer C; Grey A; Krukowski P; Brandt MD; Donix M; Linn J
    Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6015. PubMed ID: 37847104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning.
    Bangen KJ; Thomas KR; Weigand AJ; Sanchez DL; Delano-Wood L; Edmonds EC; Carmichael OT; Schwarz CG; Brickman AM; Bondi MW;
    Neurobiol Aging; 2020 Feb; 86():134-142. PubMed ID: 31791658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and specific dynamics of brain activity and connectivity in amnestic and nonamnestic mild cognitive impairment.
    Zhong X; Chen B; Hou L; Wang Q; Liu M; Yang M; Zhang M; Zhou H; Wu Z; Zhang S; Lin G; Ning Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2053-2065. PubMed ID: 35975454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension.
    Aslanyan V; Mack WJ; Ortega NE; Nasrallah IM; Pajewski NM; Williamson JD; Pa J
    Alzheimers Dement; 2024 Mar; 20(3):1784-1796. PubMed ID: 38108158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of gray matter atrophy and cognitive assessment in differentiation of aMCI and naMCI.
    Qin R; Li M; Luo R; Ye Q; Luo C; Chen H; Qian L; Zhu X; Bai F; Zhang B; Liu R; Zhao H; Xu Y
    Appl Neuropsychol Adult; 2022; 29(1):83-89. PubMed ID: 31945304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Link between Handgrip Strength and Executive Functioning: A Cross-Sectional Study in Older Adults with Mild Cognitive Impairment and Healthy Controls.
    Herold F; Labott BK; Grässler B; Halfpaap N; Langhans C; Müller P; Ammar A; Dordevic M; Hökelmann A; Müller NG
    Healthcare (Basel); 2022 Jan; 10(2):. PubMed ID: 35206845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.